Japan's Takeda to purchase U.S. cancer drugmaker ARIAD for $5.2B
January 09, 2017 at 09:43 AM EST
Andrew V. Pestano CAMBRIDGE, Mass., Jan. 9 (UPI) -- Japan's Takeda Pharmaceutical Co. said it will purchase U.S.-based cancer drugmaker ARIAD Pharmaceuticals for about $5.2 billion.
